Celgene News
Most Popular Celgene Story
Double dose of deals as Celgene buys Avila, Amgen nabs Micromet
Celgene ($CELG) snapped up Avila Therapeutics and its early-stage Btk inhibitor in a "grand slam" buyout that could hit $925 million with milestone payments. And not to be left out of the day's Read more...
Latest Headlines
- January 26, 2012
- January 6, 2012
- November 23, 2011
- September 21, 2011
- August 16, 2011
- June 17, 2011
- February 17, 2011
- February 4, 2011
- January 11, 2011
- December 20, 2010
- October 25, 2010
- August 27, 2010
- August 26, 2010
- August 25, 2010
- June 30, 2010
- June 7, 2010
- May 21, 2010
- April 30, 2010
- January 28, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
